Arcellx, Inc. Made Headway

Mon, Feb 23, 2026 at 07:28 PM

Arcellx, Inc. (ACLX:NASDAQ) soared at $113.75, a gain of 77.4%. On Mon, Feb 23, 2026, ACLX:NASDAQ touched a New 2-Week High of $113.75. The stock got featured on our News Catalysts scanner on Mon, Feb 23, 2026 at 01:56 PM in the 'ACQUISITION' category. From Mon, Feb 09, 2026, the stock recorded 33.33% Up Days and 40.00% Green Days

About Arcellx, Inc. (ACLX:NASDAQ)

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.

Top 10 Gainers:

Arcellx, Inc. (ACLX:NASDAQ), 77.43%
Tian Ruixiang Holdings Ltd (TIRX:NASDAQ), 72.73%
Signing Day Sports, Inc. (SGN:NYSEMKT), 62.47%
Klotho Neurosciences, Inc. (KLTO:NASDAQ), 62.25%
Allurion Technologies Inc. (ALUR:NYSE), 60.55%
J-Star Holding Co. Ltd. (YMAT:NASDAQ), 56.8%
Reliance Global Group Inc. (EZRA:NASDAQ), 43.07%
Vanda Pharmaceuticals Inc. (VNDA:NASDAQ), 41.49%
Jyong Biotech Ltd. (MENS:NASDAQ), 35.82%
Star Fashion Culture Holdings Limited (STFS:NASDAQ), 28.21%